SynCo completes production of AG011 for Ph II trials
SynCo Bio Partners has completed production of AG011 for ActoGenIX, enabling the latter firm to begin examining it in patients suffering from ulcerative colitis (UC).
Archives for May 18, 2008
AMRI Q1 profits hampered by lagging large scale unit
AMRI witnessed strong growth in two of its contract business during the first quarter of 2008 although profit was impacted by its dominant large-scale division, which lagged during the period.
BASF doubles certain alkylethonalamine production
Germany-based chemical company BASF has committed itself to doubling its manufacturing capacity for certain alkylethonalamines by mid 2009.
Heparin declared "safe", China remains nonchalant
The US Food and Drug Administration has declared the country's previously-tainted heparin supply to be "safe" due to stronger testing and controls that are now in place. Meanwhile, China continues to distance itself from the matter.
Tongjitang stops production at earthquake hit plant
Tongjitang Chinese Medicines, which produces traditional treatments, has stopped manufacturing operations at its facility in Guiyang, Guizhou province due to damage caused by the recent earthquake.